4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013534
Options or other derivatives
- VP and Chief Compliance Office acquired 2,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Herman James L VP and Chief Compliance Office | 2025-03-17 | Grant or award · Options (right to buy) | +2,500 | $5.17 | $12,925 | 18,500 | D |
Loading xslF345X05/wk-form4_1742332303.xml…